Literature DB >> 26054247

Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole.

Dane J Clausen1, William B Smith2, Brandon E Haines3, Olaf Wiest3, James E Bradner2, Robert M Williams4.   

Abstract

The formation of a series of analogs containing a pyridine moiety in place of the natural thiazole heterocycle, based on the potent, naturally occurring HDAC inhibitor Largazole has been accomplished. The synthetic strategy was designed modularly to access multiple inhibitors with different aryl functionalities containing both the natural depsipeptide and peptide isostere variant of the macrocycle. The cytotoxicity and biochemical activity of the library of HDAC inhibitors is described herein.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Class I Histone Deacetylase Inhibitor; Cytotoxic and biochemical assays; Largazole; Pyridine analogs

Mesh:

Substances:

Year:  2015        PMID: 26054247      PMCID: PMC4626217          DOI: 10.1016/j.bmc.2015.03.063

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  24 in total

1.  Olefin Metathesis and Beyond A list of abbreviations can be found at the end of this article.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-09-01       Impact factor: 15.336

2.  On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors.

Authors:  Di-Fei Wang; Olaf Wiest; Paul Helquist; Hsuan-Yin Lan-Hargest; Norbert L Wiech
Journal:  J Med Chem       Date:  2004-06-17       Impact factor: 7.446

3.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

4.  Distinguish protein decoys by using a scoring function based on a new AMBER force field, short molecular dynamics simulations, and the generalized born solvent model.

Authors:  Mathew C Lee; Yong Duan
Journal:  Proteins       Date:  2004-05-15

5.  Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.

Authors:  Di-Fei Wang; Paul Helquist; Norbert L Wiech; Olaf Wiest
Journal:  J Med Chem       Date:  2005-11-03       Impact factor: 7.446

Review 6.  Discovery, biological activity, synthesis and potential therapeutic utility of naturally occurring histone deacetylase inhibitors.

Authors:  Tenaya L Newkirk; Albert A Bowers; Robert M Williams
Journal:  Nat Prod Rep       Date:  2009-08-03       Impact factor: 13.423

7.  Comparative pharmacokinetic properties and antitumor activity of the marine HDACi Largazole and Largazole peptide isostere.

Authors:  John L Pilon; Dane J Clausen; Ryan J Hansen; Paul J Lunghofer; Brad Charles; Barbara J Rose; Douglas H Thamm; Daniel L Gustafson; James E Bradner; Robert M Williams
Journal:  Cancer Chemother Pharmacol       Date:  2015-01-24       Impact factor: 3.333

8.  Synthesis and histone deacetylase inhibitory activity of largazole analogs: alteration of the zinc-binding domain and macrocyclic scaffold.

Authors:  Albert A Bowers; Nathan West; Tenaya L Newkirk; Annie E Troutman-Youngman; Stuart L Schreiber; Olaf Wiest; James E Bradner; Robert M Williams
Journal:  Org Lett       Date:  2009-03-19       Impact factor: 6.005

9.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

10.  Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor.

Authors:  Albert Bowers; Nathan West; Jack Taunton; Stuart L Schreiber; James E Bradner; Robert M Williams
Journal:  J Am Chem Soc       Date:  2008-07-19       Impact factor: 15.419

View more
  6 in total

1.  Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8.

Authors:  Christophe Decroos; Dane J Clausen; Brandon E Haines; Olaf Wiest; Robert M Williams; David W Christianson
Journal:  Biochemistry       Date:  2015-03-20       Impact factor: 3.162

2.  Synthesis and biological evaluation of largazole zinc-binding group analogs.

Authors:  Bumki Kim; Ranjala Ratnayake; Hyunji Lee; Guqin Shi; Sabrina L Zeller; Chenglong Li; Hendrik Luesch; Jiyong Hong
Journal:  Bioorg Med Chem       Date:  2017-04-04       Impact factor: 3.641

Review 3.  Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects.

Authors:  Benjamín Robles-Bañuelos; Lorena María Durán-Riveroll; Edgar Rangel-López; Hugo Isidro Pérez-López; Leticia González-Maya
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

Review 4.  Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.

Authors:  Lik Tong Tan; Ma Yadanar Phyo
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

5.  Novel Methylselenoesters as Antiproliferative Agents.

Authors:  Nuria Díaz-Argelich; Ignacio Encío; Daniel Plano; Aristi P Fernandes; Juan Antonio Palop; Carmen Sanmartín
Journal:  Molecules       Date:  2017-08-02       Impact factor: 4.411

Review 6.  Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms.

Authors:  Lichuan Wu; Ke Ye; Sheng Jiang; Guangbiao Zhou
Journal:  Mar Drugs       Date:  2021-08-27       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.